Sopharma AD
Pharmaceutical producer of Rx, OTC, and plant-based medicines for international markets.
SFA | BSOBGN
Overview
Corporate Details
- ISIN(s):
- BG11SOSOBT18
- LEI:
- 097900BGGW0000048796
- Country:
- Bulgaria
- Address:
- ул. Лъчезар Станчев 5, кула А, ет.18, 1756 София
- Website:
- https://www.sopharmagroup.com/
- Sector:
- Manufacturing
Description
Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2017-11-16 13:20 |
Award from the Vienna Economic Forum “Vienna future dialogue 2017"
|
Polish | 1.8 MB | ||
| 2017-11-16 13:15 |
The company BRIZ, a subsidiary of Sopharma, was awarded with the Paracelsus awa…
|
Polish | 159.5 KB | ||
| 2017-11-06 10:46 |
Meeting with investors of Sopharma AD
|
Polish | 31.5 KB | ||
| 2017-11-03 12:01 |
Sales revenues for the first ten months of 2017
|
Polish | 26.5 KB | ||
| 2017-10-30 13:36 |
INDIVIDUAL FINANCIAL STATEMENTS FOR THE PERIOD ENDING 30 September 2017
|
Polish | 4.4 MB | ||
| 2017-10-05 13:01 |
Annual Meeting with Investors
|
Polish | 42.5 KB | ||
| 2017-10-04 14:28 |
Sales revenues for the first nine months of 2017
|
Polish | 26.0 KB | ||
| 2017-10-02 11:23 |
Current report 100 re insiders transactions -Doneva
|
Polish | 49.0 KB | ||
| 2017-09-29 13:07 |
Acquisition of own shares from 26 September 2017
|
Polish | 34.5 KB | ||
| 2017-09-28 08:56 |
Current report 98 re insiders transactions -Doneva
|
Polish | 46.5 KB | ||
| 2017-09-27 13:13 |
Notification from Sopharma AD under Art. 44n of ORDINANCE № 13 of 22.12.
|
Polish | 27.0 KB | ||
| 2017-09-27 08:52 |
Current report 96 re insiders transactions -Doneva
|
Polish | 48.5 KB | ||
| 2017-09-25 13:04 |
Acquisition of own shares - 21.09.2017
|
Polish | 34.5 KB | ||
| 2017-09-25 11:31 |
Current report 94 re insiders transactions -Donev
|
Polish | 52.0 KB | ||
| 2017-09-21 13:18 |
Current report 93 re insiders transactions - Donev Investments Holding AD
|
Polish | 52.5 KB |
Automate Your Workflow. Get a real-time feed of all Sopharma AD filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Sopharma AD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Sopharma AD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
